Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Scientific Industries (SCND) Cash & Equivalents (2016 - 2025)

Scientific Industries has reported Cash & Equivalents over the past 16 years, most recently at $5.7 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 870.4% year-over-year to $5.7 million; the TTM value through Dec 2025 reached $5.7 million, up 870.4%, while the annual FY2025 figure was $5.7 million, 870.4% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $5.7 million at Scientific Industries, down from $7.1 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $11.8 million in Q1 2022 and troughed at $351700.0 in Q1 2024.
  • A 5-year average of $3.2 million and a median of $937750.0 in 2023 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: soared 1786.31% in 2022 and later crashed 93.12% in 2023.
  • Year by year, Cash & Equivalents stood at $4.3 million in 2021, then crashed by 55.15% to $1.9 million in 2022, then plummeted by 58.69% to $796100.0 in 2023, then fell by 26.15% to $587900.0 in 2024, then soared by 870.4% to $5.7 million in 2025.
  • Business Quant data shows Cash & Equivalents for SCND at $5.7 million in Q4 2025, $7.1 million in Q3 2025, and $390900.0 in Q2 2025.